1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2016 Japan Molecular Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing (D

This DataPack contains tables from VPGMarketResearch.com new report,

"2016 Japan Molecular Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing.”

For pricing information on DataPack sections or individual tables, please contact Customer Service.

Table Of Contents

2016 Japan Molecular Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing (D


List of Tables
Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests

Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct
Identification Tests

Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct
Identification Tests

Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct
Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular
Diagnostic Tests For Genetic Diseases

Japan
Molecular Diagnostics Test Volume And Sales
By Major Application
Japan
Laboratories Performing DNA Sequencing
By Market Segment
Japan
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
Japan
Molecular Diagnostics Test Volume
By Major Application
Japan
Major Infectious Disease Test Volume by Assay
Japan
Major Infectious Disease Test Volume by Method
Japan
Molecular Diagnostics Market
By Major Application
Japan
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers
Japan
Major Infectious Disease Diagnostics Market by Assay
Japan
AIDS Testing Market
Estimated Sales by Major Supplier
Japan
Chlamydia Testing Market
Estimated Sales by Major Supplier

Japan
CMV Testing Market
Estimated Sales by Major Supplier
Japan
Gonorrhea Testing Market
Estimated Sales by Major Supplier
Japan
Hepatitis Testing Market
Estimated Sales by Major Supplier
Japan
Hepatitis C Testing Market
Estimated Sales by Major Supplier
Japan
Herpes Testing Market
Estimated Sales by Major Supplier
Japan
Meningitis Testing Market
Estimated Sales by Major Supplier
Japan
Mycoplasma Testing Market
Estimated Sales by Major Supplier
Japan
Pneumonia Testing Market
Estimated Sales by Major Supplier
Japan
Shigella Testing Market
Estimated Sales by Major Supplier

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Global Infectious Disease Testing Market: Sales and Market Shares of Major Suppliers by Test and Country

2016 Global Infectious Disease Testing Market: Sales and Market Shares of Major Suppliers by Test and Country

  • $ 11500
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report from VPGMarketResearch provides sales and market share estimates for major suppliers of infectious disease testing products by assay and country. The report also presents strategic assessments ...

2016 Europe Infectious Disease Testing Market: Sales and Market Shares of Major Suppliers by Test and Country

2016 Europe Infectious Disease Testing Market: Sales and Market Shares of Major Suppliers by Test and Country

  • $ 7800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report from VPGMarketResearch provides Europe sales and market share estimates for major suppliers of infectious disease testing products by assay and country. The report also presents strategic ...

U.S. Infectious Diseases in Hospitals, Labs, Blood Banks and POC/Point-of-Care Locations

U.S. Infectious Diseases in Hospitals, Labs, Blood Banks and POC/Point-of-Care Locations

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack  (test volumes, sales forecasts, supplier shares) $7,500. VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.